Sino Biopharmaceutical Limited (HKG:1177)

Sino Biopharmaceutical Statistics

Total Valuation

HKG:1177 has a market cap or net worth of HKD 105.30 billion. The enterprise value is 110.80 billion.

Market Cap	105.30B
Enterprise Value	110.80B

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	Jun 24, 2026

Share Statistics

HKG:1177 has 17.88 billion shares outstanding. The number of shares has decreased by -1.30% in one year.

Current Share Class	17.88B
Shares Outstanding	17.88B
Shares Change (YoY)	-1.30%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	50.78%
Owned by Institutions (%)	16.62%
Float	8.80B

Valuation Ratios

The trailing PE ratio is 40.78 and the forward PE ratio is 20.53. HKG:1177's PEG ratio is 1.03.

PE Ratio	40.78
Forward PE	20.53
PS Ratio	2.97
PB Ratio	2.25
P/TBV Ratio	4.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.03

Enterprise Valuation

EV / Earnings	42.49
EV / Sales	3.13
EV / EBITDA	13.77
EV / EBIT	16.22
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.38.

Current Ratio	1.37
Quick Ratio	1.16
Debt / Equity	0.38
Debt / EBITDA	2.18
Debt / FCF	n/a
Interest Coverage	22.60

Financial Efficiency

Return on equity (ROE) is 12.53% and return on invested capital (ROIC) is 13.52%.

Return on Equity (ROE)	12.53%
Return on Assets (ROA)	5.56%
Return on Invested Capital (ROIC)	13.52%
Return on Capital Employed (ROCE)	12.38%
Weighted Average Cost of Capital (WACC)	7.47%
Revenue Per Employee	1.65M
Profits Per Employee	121,656
Employee Count	23,056
Asset Turnover	0.45
Inventory Turnover	2.47

Taxes

In the past 12 months, HKG:1177 has paid 1.81 billion in taxes.

Income Tax	1.81B
Effective Tax Rate	23.46%

Stock Price Statistics

The stock price has increased by +57.37% in the last 52 weeks. The beta is 0.78, so HKG:1177's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	+57.37%
50-Day Moving Average	6.32
200-Day Moving Average	6.86
Relative Strength Index (RSI)	43.03
Average Volume (20 Days)	63,079,504

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1177 had revenue of HKD 35.43 billion and earned 2.61 billion in profits. Earnings per share was 0.14.

Revenue	35.43B
Gross Profit	29.07B
Operating Income	7.00B
Pretax Income	7.73B
Net Income	2.61B
EBITDA	8.22B
EBIT	7.00B
Earnings Per Share (EPS)	0.14

Balance Sheet

The company has 25.09 billion in cash and 17.88 billion in debt, with a net cash position of 7.21 billion or 0.40 per share.

Cash & Cash Equivalents	25.09B
Total Debt	17.88B
Net Cash	7.21B
Net Cash Per Share	0.40
Equity (Book Value)	46.83B
Book Value Per Share	1.91
Working Capital	10.31B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	1.24B
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 82.07%, with operating and profit margins of 19.76% and 7.36%.

Gross Margin	82.07%
Operating Margin	19.76%
Pretax Margin	21.81%
Profit Margin	7.36%
EBITDA Margin	23.19%
EBIT Margin	19.76%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.70%.

Dividend Per Share	0.10
Dividend Yield	1.70%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	1.30%
Shareholder Yield	3.00%
Earnings Yield	2.48%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 20, 2020
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5